Humira 40 mg/0.8 mL in a single-dose pen Images
Generic Name: adalimumab
This medication has been identified as Humira 40 mg/0.8 mL in a single-dose pen. It is supplied by AbbVie Inc.
Humira is used in the treatment of Ankylosing Spondylitis; Crohn's Disease; Crohn's Disease, Active; Crohn's Disease, Maintenance; Hidradenitis Suppurativa and belongs to the drug classes antirheumatics, TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Humira 40 mg/0.8 mL in a single-dose pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Humira
- Generic Name
- adalimumab
- Strength
- 40 mg/0.8 mL in a single-dose pen
- Availability
- Prescription only
- Drug Class
- Antirheumatics, TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 00074-4339
More about Humira (adalimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (680)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
- Humira drug information
- Humira Pen
- Humira Pediatric Crohns Start
- Humira Pen-CD/UC/HS Starter
- Humira Pen-Ps/UV Starter
Other brands
Amjevita, Hyrimoz, Hadlima, Idacio, ... +6 more
Professional resources
Other brands
Amjevita, Hyrimoz, Hadlima, Idacio, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
